Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA pseudogene 128 (RNA5SP128) is a processed pseudogene in the human genome, corresponding to a nonfunctional duplicate of the 5S ribosomal RNA gene[2]. Like other pseudogenes, it cannot produce functional 5S rRNA due to disabling mutations or sequence changes. 5S rRNA itself is a short RNA component (~120 nucleotides) of the large ribosomal subunit, critical for ribosome structure and function in active genes[1][3]. Pseudogenes such as RNA5SP128 are typically considered "genomic fossils," but some are transcriptionally active and may have regulatory functions at the RNA level, such as acting as antisense transcripts or miRNA sponges, though specific evidence for RNA5SP128 is not documented[2]. RNA5SP128 is not a protein, not a therapeutic target (it is neither a receptor, enzyme, transporter, nor druggable molecule), and does not have known drug interactions. RNA5SP128 (5S ribosomal RNA pseudogene 128) is an unprocessed or processed pseudogene of the 5S ribosomal RNA gene, not a therapeutic target, with no known function, drug interactions, or clinical relevance as a biomarker or safety concern[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 128 (RNA5SP128).